Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

finscreener stocktwits page

Avenue Therapeutics, Inc.

NASDAQ: ATXIHealthcare / Drug Manufacturers - Other / -
4.9500.00Vol 44 3161Y Perf 0.43%
Dec 10th, 2018 14:08
BID4.75 ASK4.94
Open4.91 Previous Close4.95
Pre-Market- After-Trading-
 - -%  - -%
Target Price
13.33 
Analyst Rating
Strong Buy 1.00
Potencial %
182.42 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/-/100 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-/-/100 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12M
-/-/100 
Income Ranking
 —    -
Market Cap (mil)53 
Earnings Rating
Strong Sell
Price Range Ratio 52wk %
73.21 
Earnings Date
15th Nov 2018

Today's Price Range

4.624.95

 

52wk Range

2.086.00

Summary:

Sell

Technical Indicators: Sell
Moving Averages: Strong Sell
Performance
1 Month
19.57%
3 Months
41.43%
6 Months
15.12%
1 Year
0.43%
3 Years
-
5 Years
-

Quotes

Name / TickerPriceChg.Chg.%
ATXI4.950.00000.00
AAPL168.730.24000.14
GOOG1 038.381.80000.17
MSFT106.391.57001.50
XOM75.67-1.9700-2.54
WFC48.71-1.5500-3.08
JNJ144.72-0.7100-0.49
FB140.823.40002.47
GE6.90-0.1100-1.57
JPM100.95-2.3400-2.27
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio
1.90
Current Ratio
2.10
Long Term Debt to Total Capital
0.01
Total Debt to Equity
0.00
Interest Coverage
-227.50
Leverage Ratio 1.40
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin
-
EBIT Margin
-
EBITDA Margin
-
Pre-tax Profit Margin
-
Profit Margin
-
ValuationValueIndustryS&P 500US Markets
PE Ratio
-
PB Ratio
8.06
PS Ratios
-
Price to Cash Flow
-
Price to Free Cash Flow
-2.10
Cash Flow Per Share
-1.88
Price to Tangible Book
8.06
Book Value per Share
0.48
Enterprise Value (in ths.)
31 483
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)
-
ROE last 12 Months
-176.96
Return on Assets (5Y Avg)
-
ROA last 12 Months
-151.86
Return on Capital (5Y Avg)
-
ROC last 12 Months
-178.20
Return on invested Capital Q
-66.78
Return on invested Capital Y
-215.07
Assets Turnover
0.00
Receivables Turnover
-
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)
0
Revenue per Share
0.00
Revenue Growth 3 Years
-
Revenue Growth 5 Years
-
DividendsValueIndustryS&P 500US Markets
Dividend Yield
-
Dividend Rate
-
Dividend Growth 3 Years
-
Dividend Growth 5 Years
-

Earnings HistoryEstimateReportedSurprise %
Q03 2018-0.35-0.2528.57
Q02 2018-0.72-0.4537.50
Q01 2018-0.68-1.03-51.47
----
----
----
----
----
Earnings Per EndEstimateRevision %Trend
12/2018 QR-0.47-20.51Negative
12/2018 FY-2.19-2.34Negative
3/2019 QR-0.4716.07Positive
12/2019 FY-1.679.24Positive
Next Report Date-
Estimated EPS Next Report-0.35
Estimates Count3
EPS Growth Next 5 Years %-
Volume Overview
Volume44 316
Shares Outstanding (in ths.)10 660
Trades Count129
Dollar Volume201 797
Avg. Volume47 890
Avg. Weekly Volume35 969
Avg. Monthly Volume135 257
Avg. Quarterly Volume99 137

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

67%33%

Bearish Bullish

38%63%

Bearish Bullish

56%44%

Bearish Bullish

59%41%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
2 (100.00 %)
2 (100.00 %)
2 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

There are no comments yet.

News